Skip to main content

Iran's supreme leader bans vaccines made in US, UK

Supreme Leader Ayatollah Ali Khamenei said he had "no confidence" in the American or British-made vaccinations.
DESSAU, GERMANY - NOVEMBER 23: An employee holds an ampoule into which the vaccine is later filled as German Health Minister Jens Spahn tours the lab facilities of vaccine maker IDT Biologika during the second wave of the coronavirus pandemic on November 23, 2020 in Dessau, Germany. IDT Biologika is currently conducting human trials for its potential vaccine against Covid-19. During the company visit, Spahn announced the planned purchase at least five million vaccine doses.  (Photo by Hendrik Schmidt-Pool/G

Iran’s Supreme Leader Ayatollah Ali Khamenei says he has banned the government from importing COVID-19 vaccines made in the United States or United Kingdom even as his country grapples with the worst coronavirus outbreak in the region. 

“Imports of US and British vaccines into the country are banned. I have told this to officials, and I'm saying it publicly now," Khamenei said, according to a Reuters translation of televised remarks. "I have no confidence in them,” he said. “If the Americans were able to produce a vaccine, they would not have such a coronavirus fiasco in their own country."

“Given our experience with France’s HIV-tainted blood supplies, French vaccines aren’t trustworthy either,” Khamenei said in a reference to France’s scandal involving contaminated blood transfusions during the AIDS epidemic.

The Iranian Red Crescent Society said in a statement Friday that it would no longer deliver 150,000 doses of the Pfizer-BioNTech vaccine the organization said had been donated by overseas benefactors. 

Iran, which in late December launched human trials of its own vaccine, has sought supplies elsewhere. The Red Crescent said last week that China would donate one million doses to Iran. Separately, the Central Bank of Iran said would pay for 16.8 million doses through the World Health Organization’s COVAX initiative, a purchasing pool to deliver vaccinations to poorer countries. 

Iran remains the epicenter of the coronavirus outbreak in the Middle East. The Iranian Health Ministry recorded 6,251 cases on Friday, raising the country’s total number of infections since February to more than 1.2 million. With the addition of 85 more fatalities, the official death toll now stands at 56,018. 

On Tuesday, Iran reported its first case of the new coronavirus variant, which emerged in the United Kingdom last month and is believed by some experts to be more contagious. Health Minister Saeed Namaki said the patient is an Iranian citizen who flew home from the United Kingdom and is now receiving treatment in a private hospital. 

Tensions between Iran and the West are running high over the anniversary of Iranian commander Qasem Soleimani’s death and the Donald Trump administration’s continued sanctions campaign. 

Iran’s leaders say the harsh economic sanctions, which Washington reimposed after pulling out of the landmark Iranian nuclear agreement in 2018, have made it difficult for their country to access vaccines. The Trump administration maintains that vaccines and other humanitarian supplies are exempt from the sanctions.  

President-elect Joe Biden has pledged to return the United States to the nuclear accord if Tehran meets its obligations under the deal. On Monday, Iran announced that its Fordow nuclear facility has resumed enriching uranium to 20%, a major breach of the original agreement. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Already a Member? Sign in


The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.


What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial
What's included:
Our Expertise

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

We also offer team plans. Please send an email to and we'll onboard your team.

Already a Member? Sign in